Stock ENLV ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/07/2024 am IST 		5-day change 1st Jan Change
1.38 USD -2.82% Intraday chart for Enlivex Therapeutics Ltd. -2.13% -48.89%
24/06 Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial MT
24/06 Enlivex Therapeutics Ltd. Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENLIVEX THERAPEUTICS LTD. Stock Enlivex Therapeutics Ltd.
 29.64M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.02B -
BIONTECH SE Stock BioNTech SE
 19.39B -
GENMAB A/S Stock Genmab A/S
 15.91B
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Charts Enlivex Therapeutics Ltd.
  5. Sector Chart